The Pharma Data

DECEMBER 3, 2020

The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e.,

Treatment 52

Treatment Pharmaceutical Companies Therapies Virus 52

Codon

OCTOBER 27, 2024

The Most Deadly Infectious Disease “Each successive episode of bleeding left him weaker than before,” wrote Mary Doria Russell of Doc Holliday, the gunslinging gambler, in her eponymous book, Doc. .’ ” Doc suffered from tuberculosis, or TB, a bacterial disease caused by Mycobacterium tuberculosis.

Immune Response 77

Immune Response Doctors Disease Laboratories 77

Codon

NOVEMBER 3, 2024

In the 1924 novel, The Magic Mountain , Thomas Mann describes a sanatorium patient named Anton Ferge as he undergoes a painful tuberculosis (TB) treatment. Physicians working in the early 20th century had little choice but to treat the world’s most rampant infectious disease with methods such as these. million people every year.

Vaccine 83

Vaccine Trials Therapies Treatment 83

Eye on FDA

DECEMBER 15, 2021

We have the emergence of monoclonal antibodies and protease inhibitors being utilized or being considered as treatments for various stages of disease. We even have a pile of misinformation.

Vaccine 72

Vaccine Nurses Virus Treatment 72

The Pharma Data

NOVEMBER 19, 2020

A study out of Rutgers University found that healthcare staffers, especially nurses, have a higher prevalence of COVID-19 than non-healthcare workers. Centers for Disease Control and Prevention (CDC), there were more than 216,000 confirmed COVID-19 cases in healthcare workers in the U.S., As of November 15, 2020, according to the U.S.

Research 52

Research Nurses Disease Immune Response 52

Codon

JANUARY 21, 2024

Today, refined versions of these human challenge studies have become standard practice in testing vaccines for vector-borne diseases (e.g., yellow fever, malaria, and dengue), evaluating new drugs or treatments, and studying pathogenesis, the process by which a disease develops.

Vaccine 108

Vaccine Trials Disease Treatment 108

The Pharma Data

NOVEMBER 6, 2020

Parents and physicians should be aware that morning joint stiffness may indicate early disease symptoms of polyarticular JIA and serve as a more reliable indicator than pain. Polyarticular JIA is a chronic form of the disease with symptoms of pain, swelling, stiffness or warmth in four or more joints. NEW YORK , Nov.

Nurses 52

Nurses Hospitals Disease Therapies 52

Altus Drug Development

MAY 31, 2022

Value-added medicines offer the medical world the opportunity to increase the quality of treatments as well as expand access to healthcare for more people. Value-added medicines are drug products and treatments created using known molecules through a process known as drug repositioning. What is a value-added medicine?

Treatment 52

Treatment Pharmaceuticals Production Doctors 52

The Pharma Data

JANUARY 26, 2021

While the preliminary nature of Phase 2 results from COVID-19 neutralizing monoclonal antibodies may have limited acceptance of treatment, these Phase 3 data further strengthen the available evidence,” said Daniel Skovronsky, M.D., Lilly’s chief scientific officer and president of Lilly Research Laboratories.

Hospitals 52

Hospitals Treatment Trials Long-Term Care Facilities 52

The Pharma Data

JUNE 18, 2021

“The CLL14 trial results observed after four years of follow-up with treatment of venetoclax plus obinutuzumab show that these patients can experience long-lasting responses without disease progression, years after stopping treatment,” said Mohamed Zaki , M.D., NORTH CHICAGO, Ill. 0.45]); results are descriptive.

Treatment 40

Treatment Trials Therapies Clinical Trials 40

The Pharma Data

AUGUST 11, 2020

.–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -577 trial evaluating Opdivo (nivolumab) as an adjuvant therapy for patients with resected esophageal or gastroesophageal junction (GEJ) cancer met its primary endpoint of disease-free survival (DFS) at a pre-specified interim analysis.

Therapies 52

Therapies Trials Disease Treatment 52

The Pharma Data

SEPTEMBER 23, 2020

‘A scary time’ Clementine Stott, an organ donation specialist nurse at Worcester Royal Hospital, was redeployed to the intensive care unit during the first wave which, for her, meant separating from her 10-year-old son for seven weeks. We spoke to medical staff to see how they were approaching the possible fresh wave of cases.

Nurses 52

Nurses Hospitals Virus Disease 52

The Pharma Data

JANUARY 27, 2021

The report entitled “Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women” was written by nurse practitioner Melissa Fesler and internist Raphael Stricker from the Alan E. This antimicrobial agent was originally promoted for treatment of severe SARS-CoV-2 infection using high daily doses in combination with other medications.

Vaccine 52

Vaccine Nurses International Treatment 52

The Pharma Data

NOVEMBER 4, 2020

The retrospective study shows that prespecified triggers of aHUS were reported in approximately one-third of patients with aHUS, and that long-term clinical disease manifestations persisted in the majority of patients with aHUS who were not treated with SOLIRIS ® (eculizumab). In addition, an observational analysis of U.S. About ULTOMIRIS ®.

Doctors 52

Doctors Vaccine Nurses Treatment 52

The Pharma Data

AUGUST 11, 2020

Responses to the current standard chemotherapy in patients are short lived, and less than 6% of patients with metastatic disease survive beyond five years,” said Yelena Y. We look forward to engaging health authorities worldwide with the goal of bringing this immunotherapy-based treatment option to patients as soon as possible.”.

Treatment 52

Treatment Trials Therapies Clinical Trials 52

The Pharma Data

OCTOBER 25, 2020

Food and Drug Administration (“FDA”) for the treatment of agitation associated with delirium. Treatment choices are limited, and commonly used off-label therapies are not always effective or may result in prolonged, deep sedation. This condition may be caused by numerous underlying pathologic processes and disease states.

Treatment 52

Treatment Trials FDA Hospitals 52

The Pharma Data

JUNE 18, 2021

. “We are encouraged by these promising results, which indicate ibrutinib and venetoclax combined has the potential to serve as an important chemotherapy-free, fixed-duration treatment option for people living with CLL,” said Dr. Paolo Ghia , M.D., 95% irrespective of subsequent randomized treatment ( Wierda, ASH 2020 ).

Treatment 40

Treatment FDA Therapies FDA Approval 40

Altus Drug Development

MAY 31, 2022

However, many patients end up having to face the fact that many treatments are unfeasible, too expensive, or potentially counter-conducive. The purpose of value-added medicines is to create innovative treatments for patients while offering convenient solutions to healthcare professionals. What are value-added medicines?

Pharmaceuticals 52

Pharmaceuticals Treatment Packaging Doctors 52

The Pharma Data

MAY 13, 2021

You should not construe ClickBank’s sale of this product as an endorsement by ClickBank of the views expressed herein, or any warranty or guarantee of any strategy, recommendation, treatment, action, or application of advice made by the author of the product. Products are not intended to diagnose, treat, cure or prevent any disease.

Production 52

Production Testimonials Nurses Licensing 52

The Pharma Data

OCTOBER 19, 2020

To accommodate cost-effective delivery outside of specialty dialysis facilities, hemodialysis machines need to be user friendly for non-specialty nurses, patients, and care partners,” says Osman Khawar , M.D., Chief Executive Officer at Diality.

Nurses 52

Nurses Production Treatment Marketing 52

The Pharma Data

NOVEMBER 20, 2020

20, 2020 (American Heart Association News) — Heart disease and depression are interwoven, and a new study is helping unravel that connection by linking depression with poorer scores on seven important measures of heart health. People with depression are more likely to develop heart disease. FRIDAY, Nov. That is “critical.

Disease 52

Disease Nurses Research Hospitals 52

The Pharma Data

JANUARY 24, 2021

It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. It will be run through the NIAID-supported Infectious Diseases Clinical Research Consortium (IDCRC), with support from the Bill & Melinda Gates Foundation. Non-COVID-19-Related.

Long-Term Care Facilities 52

Long-Term Care Facilities Trials Virus Clinical Trials 52

The Pharma Data

DECEMBER 1, 2020

13 to 17 and attracted participants from around the world, including cardiovascular specialists, surgeons, and nurses as well as other health care professionals. The researchers found that increased greenness and air quality reduced cardiovascular disease mortality. In a cross-sectional study, William Aitken, M.D., born Black women.

Hospitals 52

Hospitals Disease Treatment Therapies 52

The Pharma Data

JULY 23, 2021

Food and Drug Administration (FDA) approved DALVANCE® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients from birth. “This pediatric approval for DALVANCE as a single-dose provides a meaningful contribution to the treatment of children and infants with ABSSSI.”

FDA Approval 52

FDA Approval FDA Clinical Trials Trials 52

The Pharma Data

DECEMBER 17, 2020

These follow-on data provided the first definitive prospective evidence demonstrating anti-viral activity for a treatment regimen now available for COVID-19, and also further documented the ability of this treatment to decrease the need for further medical attention,” said George D. Yancopoulos , M.D.,

Hospitals 52

Hospitals Production Clinical Trials Therapies 52

The Pharma Data

MARCH 25, 2021

“With more than six years of patient experience, a positive benefit-risk profile, strong clinical data and robust real-world data, the totality of evidence solidifies the role of IBRANCE plus endocrine therapy as a treatment for patients with HR+, HER2- metastatic breast cancer.”. The analysis also showed the two-year OS rate was 78.3%

Therapies 52

Therapies Clinical Trials Trials Treatment 52

The Pharma Data

NOVEMBER 20, 2020

Importantly, we continue to advance our rigorous clinical trial program evaluating the safety and efficacy of the antibody cocktail for both the treatment and prevention of COVID-19, and we will share new results as available.”. Food and Drug Administration (FDA). Department of Health and Human Services.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

SEPTEMBER 16, 2020

The US Centers for Disease Control and Prevention’s list of symptoms also includes chills, repeated shaking, muscle pain, sore throat, nausea or vomiting and diarrhoea. The main reason people need hospital treatment is difficulty breathing. You should also have a test to confirm whether or not you have the virus.

Virus 52

Virus Nurses Hospitals Doctors 52

The Pharma Data

JUNE 18, 2021

The study met its primary endpoint of superior progression-free survival (PFS) as assessed by an independent review committee (IRC) with a HR 0.216 (95% CI, 0.131-0.357; p < 0.0001), demonstrating a reduction in the risk of disease progression or death for I+V of approximately 78% compared to C+O. and 17.1%, respectively.

Treatment 52

Treatment Therapies FDA FDA Approval 52

The Pharma Data

JANUARY 12, 2021

Patients, caregivers and healthcare providers can find sites with COVID-19 antibody treatments through these links to the HHS or National Infusion Center Association locator tools. . Regeneron is responsible for development and distribution of the treatment in the U.S. , .” The U.S. In the U.S.

Government 52

Government Hospitals Virus Clinical Trials 52

PLOS: DNA Science

MARCH 30, 2023

. “What is different and particularly scary about Candida auris is that it can survive on skin and healthcare surfaces up to two weeks, allowing the spread from person-to-person in healthcare settings and nursing homes. The agency started tracking it in 2013, and the spread accelerated in 2015. The search is on for new antifungals.

DNA 52

DNA Hospitals Laboratories Virus 52

The Pharma Data

DECEMBER 9, 2020

The patient improved after treatment with anti-inflammatory corticosteroids. At this point, doctors have learned more about managing COVID, in ways that can help prevent neurologic complications, said Dr. Aaron Glatt, a spokesperson for the Infectious Diseases Society of America. In her study group, 10 patients died in the hospital.

Hospitals 52

Hospitals Doctors Immune Response Virus 52

The Pharma Data

FEBRUARY 8, 2021

IBRANCE is indicated for the treatment of adult patients with HR+, HER2- advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women or in men; or with fulvestrant in patients with disease progression following endocrine therapy. 2,3 In the U.S.,

Clinical Trials 52

Clinical Trials Treatment Therapies Production 52

The Pharma Data

DECEMBER 29, 2020

The benefit was driven by results starting one week post-treatment, when the risk of death or receiving mechanical ventilation was reduced by approximately half with antibody cocktail treatment, based on a post-hoc analysis. The results passed the futility analysis (p<0.3 Under an agreement with the U.S.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

The Pharma Data

APRIL 28, 2021

“This positive CHMP opinion for VENCLYXTO in acute myeloid leukemia is a critical step to providing new therapeutic options in the European Union for patients with this devastating disease,” said Mohamed Zaki , M.D., 1 An estimated 160,000 people are currently living with the disease globally. NORTH CHICAGO, Ill.

Clinical Trials 40

Clinical Trials Trials Therapies Treatment 40

The Pharma Data

NOVEMBER 21, 2020

21, 2020 /PRNewswire/ — First treatment of any kind to have prospectively confirmed and statistically significant anti-viral activity against SARS-CoV-2. The FDA grants Emergency Use Authorization to medicines that may help diagnose, treat or prevent a life-threatening disease when adequate and approved alternatives are not available.

FDA 40

FDA Clinical Trials Hospitals Production 40

The Pharma Data

MAY 15, 2021

Second surprise was that there are drug treatments for osteoporosis – as we might expect – but they’re long-term, unreliable and riddled with side-effects. And I’m not ashamed to say that, even though I had supportive family and friends, I felt very alone with the disease. . Plus, possibly, others. Which led to the third surprise. .

Disease 52

Disease Treatment Production Doctors 52